Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects
NCT02463045 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 67
Last updated 2017-05-23
Summary
This study evaluates the safety and tolerability of TOP1288 rectal single and multiple ascending doses in healthy subjects and multiple doses in subjects with ulcerative colitis.
Conditions
Interventions
- DRUG
-
TOP1288
Sponsors & Collaborators
-
Topivert Pharma Ltd
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-05-31
- Primary Completion
- 2016-07-31
- Completion
- 2016-07-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
A Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)
NCT07062185 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study of NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis
NCT06681389 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Pharmacokinetic Study of LYC-30937 in Subjects With Active Ulcerative Colitis
NCT02818543 ·Status: COMPLETED ·Phase: PHASE1
-
Tofacitinib in Adult Patients With Moderate to Severe Ulcerative Colitis
NCT04424303 ·Status: COMPLETED
-
Safety and Pharmacokinetics Study of HE3286 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
NCT00628433 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
NCT03943550 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
NCT02435992 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral BT-11 in Ulcerative Colitis
NCT03861143 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181 in Healthy Subjects and Subjects With Mild to Moderate Ulcerative Colitis
NCT01164904 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
NCT04596293 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
NCT00694980 ·Status: COMPLETED ·Phase: PHASE1
-
A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis
NCT01458951 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
NCT04624230 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336 ·Status: RECRUITING ·Phase: PHASE2
-
Safety, Tolerability and Pharmacokinetics of Oral NX-13 in Healthy Adults Male and Female Volunteers
NCT04458805 ·Status: COMPLETED ·Phase: PHASE1
-
An Investigation of Oral BT051 in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)
NCT05084261 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of Two Adalimumab Dosing Regimens in Subjects With Moderate to Severe Ulcerative Colitis
NCT02065622 ·Status: COMPLETED ·Phase: PHASE3
-
A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis
NCT06080048 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis
NCT03653026 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of TLL018 in the Treatment of Ulcerative Colitis
NCT05121402 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis.
NCT02840721 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Pharmacodynamics, Safety and Tolerability of Oral BL-7040 in Patients With Moderately Active Ulcerative Colitis
NCT01506362 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Long-term Safety of Etrolizumab in Participants With Moderate to Severe Ulcerative Colitis
NCT01461317 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
NCT02065557 ·Status: COMPLETED ·Phase: PHASE3
-
Compare the Pharmacokinetics, Pharmacodynamics and Safety/Tolerability of LC51-0255 Film-coated Tablet (SG85) With LC51-0255 Uncoated Tablet (SG82) in Healthy Subjects
NCT04360343 ·Status: COMPLETED ·Phase: PHASE1